Background: Stem cells isolated from amniotic fluid are known to be able to differentiate into different cells types, being thus considered as a potential tool for cellular therapy of different human diseases. In the present study, we report a novel single step protocol for the osteoblastic differentiation of human amniotic fluid cells. Results: The described protocol is able to provide osteoblastic cells producing nodules of calcium mineralization within 18 days from withdrawal of amniotic fluid samples. These cells display a complete expression of osteogenic markers (COL1, ONC, OPN, OCN, OPG, BSP, Runx2) within 30 days from withdrawal. In order to test the ability of these cells to proliferate on surfaces commonly used in oral osteointegr...
New technologies in orthopedic and maxillofacial surgery are generating an increasing demand of biom...
Background: The aim of this study is to evaluate the effects of recombinant human bone morphogenetic...
[Excerpt] The potential immune privilege presented by mesenchymal stem cells (MSCs) makes them a pro...
In tissue engineering, stem cells have become an ideal cell source that can differentiate into most ...
AbstractCell based therapies for bone regeneration are an exciting emerging technology, but the avai...
The role of stem cells in tissue engineering and regenerative medicine is evolving rapidly, namely t...
Abstract Background Human amniotic fluid stem (hAFS) cells have become an attractive stem cell sourc...
<div><p>Human stem cells and progenitor cells can be used to treat cancer and replace dysfunctional ...
Human stem cells and progenitor cells can be used to treat cancer and replace dysfunctional cells wi...
Insufficient availability of osteogenic cells limits bone regeneration through cell-based therapies....
Tissue engineering strategies usually require cell isolation and combination with a suitable biomate...
OBJECTIVES: Articular cartilage is vulnerable to injuries and undergoes an irreversible degenerative...
To investigate the potential of human amniotic mesenchymal cells (hAMC) serving as seeding cells in ...
Objective: Human amniotic fl uid stem cells (HAFSCs) derived from human amniotic fl uid during partu...
Cell based therapies for bone regeneration are an exciting emerging technology, but the availability...
New technologies in orthopedic and maxillofacial surgery are generating an increasing demand of biom...
Background: The aim of this study is to evaluate the effects of recombinant human bone morphogenetic...
[Excerpt] The potential immune privilege presented by mesenchymal stem cells (MSCs) makes them a pro...
In tissue engineering, stem cells have become an ideal cell source that can differentiate into most ...
AbstractCell based therapies for bone regeneration are an exciting emerging technology, but the avai...
The role of stem cells in tissue engineering and regenerative medicine is evolving rapidly, namely t...
Abstract Background Human amniotic fluid stem (hAFS) cells have become an attractive stem cell sourc...
<div><p>Human stem cells and progenitor cells can be used to treat cancer and replace dysfunctional ...
Human stem cells and progenitor cells can be used to treat cancer and replace dysfunctional cells wi...
Insufficient availability of osteogenic cells limits bone regeneration through cell-based therapies....
Tissue engineering strategies usually require cell isolation and combination with a suitable biomate...
OBJECTIVES: Articular cartilage is vulnerable to injuries and undergoes an irreversible degenerative...
To investigate the potential of human amniotic mesenchymal cells (hAMC) serving as seeding cells in ...
Objective: Human amniotic fl uid stem cells (HAFSCs) derived from human amniotic fl uid during partu...
Cell based therapies for bone regeneration are an exciting emerging technology, but the availability...
New technologies in orthopedic and maxillofacial surgery are generating an increasing demand of biom...
Background: The aim of this study is to evaluate the effects of recombinant human bone morphogenetic...
[Excerpt] The potential immune privilege presented by mesenchymal stem cells (MSCs) makes them a pro...